Gene Therapy Holds Promise as Parkinson’s Disease Treatment

Posted on 2009-10-20 06:00:00 in Gene Therapy | Parkinsons Disease |

Affecting more than 4 million people worldwide, Parkinson’s Disease (PD) is a chronic motor system disorder characterized by tremor, rigidity; bradykinesia (slowness of movement) and postural instability.  There presently is no cure, and medications, while offering symptom control, can become less effective over time.  Bechir Jarraya, from the department of neurosurgery at Henri-Mondor Hospital (Paris, France), and colleagues inserted genes into brain cells of Macaque monkeys induced to have PD-like symptoms, in an effort to resume production of dopamine, the neurotransmitter that is thought to be deficient in PD patients and the cause of the neurological manifestations.  They restored dopamine at about 50% of normal concentrations, resulting in motor improvements without the side effects seen with conventional drugs. The benefits were sustained for up to 44 months.   Commenting that: “Gene therapy–mediated dopamine replacement may be able to correct Parkinsonism in patients without the complications of dyskinesias,” the team is hopeful that these advancements will herald innovations that may be applied to humans afflicted with Parkinson’s Disease.

Bechir Jarraya, Sabrina Boulet, G. Scott Ralph, Caroline Jan, Gilles Bonvento, Mimoun Azzouz, James E. Miskin, Masahiro Shin, Thierry Delzescaux, Xavier Drouot, Anne-Sophie Herard, Denise M. Day, Emmanuel Brouillet, Susan M. Kingsman, Philippe Hantraye, Kyriacos A. Mitrophanous, Nicholas D. Mazarakis, Stephane Palfi.   “Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia.”  Sci Transl Med 14 October 2009 1:2ra4. DOI:10.1126/scitranslmed.3000130


Health Headlines

Among women ages 65+, German researchers find that 18 months of exercise yielded denser bones and a reduced risk of falls.
Years prior to onset of symptoms, rheumatoid arthritis may be prompted by the accumulation of markers of inflammation in the blood.
Harvard Medical School team finds that 12% of American children and teens use Complementary/Alternative Medicine (CAM).
By as early as 7 years of age, being obese may raise a child's risk of future heart disease and stroke, even in the absence of other cardiovascular risk factors
Stanford University (US) researchers transform ordinary mouse skin cells directly into neurons, bypassing the need for stem cells.
German researchers find that moderate or high physical activity may lower the risk of developing cognitive impairment as we age.
Chronic insomniacs are at risk for reduced cortical volume of the brain.
Many of the health benefits of aerobic exercise may be profoundly affected by the food we eat afterwards.
Learning abilities, working memory, and short- and long-term memory may improve with increased magnesium intake.
New York University (US) researchers find that wakeful rest periods, such as coffee breaks or meditation, may help improve learning and memory.
Get our Anti-Aging Weekly Newsletter! Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Orlando
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010
workshop
workshops
International Events
See all events »